Lumacaftor/ivacaftor-associated health stabilisation in adults with severe cystic fibrosis

King, SJ; Keating, D; Williams, E; Paul, E; Borg, BM; Finlayson, F; Button, BM; Wilson, JW; Kotsimbos, T

King, SJ (corresponding author), Alfred Hosp, Nutr Dept, Commercial Rd, Melbourne, Vic 3004, Australia.

ERJ OPEN RESEARCH, 2021; 7 (1):

Abstract

Introduction: Lumacaftor/ivacaftor (LUM/IVA) has been shown to improve clinical outcomes in cystic fibrosis (CF) patients homozygous for Phe508del wit......

Full Text Link